Fig. 5From: Assessment of the results and hematological side effects of 3D conformal and IMRT/ARC therapies delivered during craniospinal irradiation of childhood tumors with a follow-up period of five yearsProgression-free survival. All patient curves over the years. 3DCRT in blue and IMRT/ARC in orangeBack to article page